Newer insulin may reduce dangerous low blood sugar in youth with Type 1 diabetes in low-resource settings
A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogues […]
















